Cholecystokinin-8 vs Insulin Degludec

Head-to-head comparison of Cholecystokinin-8 (Cholecystokinin (sulfated C-terminal octapeptide, CCK-8)) and Insulin Degludec (Insulin degludec (desB30, acylated ultra-long-acting insulin analog)) — benefits, dosing, side effects, research data, and where to buy.

PropertyCholecystokinin-8Insulin Degludec
CategoryEndocrine PeptidesDiabetes & Metabolic
Full NameCholecystokinin (sulfated C-terminal octapeptide, CCK-8)Insulin degludec (desB30, acylated ultra-long-acting insulin analog)
Molecular Weight1143.2 Da6103.9 Da
Half-Life1-2 minMore than 25 hours
Amino AcidsDY(SO3H)MGWMDF-NH250
Typical Dosephysiologic low-picomolar-nanomolar range|research-dependent0.1-0.2 U/kg once daily
Routeendogenous secretion|research IV/SCSubcutaneous
Purity≥98%≥98%
Studies Count977000
Research StatusEndogenousApproved

Cholecystokinin-8 Benefits

  • gallbladder contraction
  • pancreatic enzyme release
  • satiety signaling

Insulin Degludec Benefits

  • Ultra-long basal coverage
  • Lower day-to-day variability
  • Reduced nocturnal hypoglycemia
  • Flexible dosing time

Cholecystokinin-8 Dosing

physiologic secretion|research-dependent

Insulin Degludec Dosing

Inject SC once daily|Titrate to fasting glucose and HbA1c response|May be administered with flexible timing in adults

Cholecystokinin-8 Side Effects

  • abdominal cramping
  • nausea
  • biliary contraction

Insulin Degludec Side Effects

  • Hypoglycemia
  • Injection-site reactions
  • Weight gain

Research Overview

Cholecystokinin-8

CCK-8 is a canonical gut hormone fragment with extensive documentation in digestive physiology and appetite control. Sulfation of the tyrosine residue is important for high-affinity receptor activity.

Insulin Degludec

Studies highlight prolonged action and lower glycemic variability compared with many other basal insulins. It is frequently used in research on ultra-long basal coverage and hypoglycemia reduction.

Ready to buy?

Find both peptides from our verified, lab-tested vendors with purity certificates and third-party testing.

Common Stacking Partners

Cholecystokinin-8 stacks with:

gallbladderpancreassatiety

Insulin Degludec stacks with:

Insulin LisproInsulin Aspart
gut-hormonesatiety-peptideendocrine-peptideultra-long-acting insulinbasal controllow variability